Article ; Online: Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas.
Journal of magnetic resonance imaging : JMRI
2022 Volume 57, Issue 1, Page(s) 308–317
Abstract: ... Reporting and Data System (LI-RADS) (LR)-M lesions.: Purpose: To compare overall survival (OS) and ... M criteria and to evaluate factors associated with prognosis.: Study type: Retrospective ... Subjects: Patients at risk for HCC with at least one LR-M lesion with histologic diagnosis, from 8 ...
Abstract | Background: There is a sparsity of data evaluating outcomes of patients with Liver Imaging Reporting and Data System (LI-RADS) (LR)-M lesions. Purpose: To compare overall survival (OS) and progression free survival (PFS) between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA) meeting LR-M criteria and to evaluate factors associated with prognosis. Study type: Retrospective. Subjects: Patients at risk for HCC with at least one LR-M lesion with histologic diagnosis, from 8 academic centers, yielding 120 patients with 120 LR-M lesions (84 men [mean age 62 years] and 36 women [mean age 66 years]). Field strength/sequence: A 1.5 and 3.0 T/3D T Assessment: The imaging categorization of each lesion as LR-M was made clinically by a single radiologist at each site and patient outcome measures were collected. Statistical tests: OS, PFS, and potential independent predictors were evaluated by Kaplan-Meier method, log-rank test, and Cox proportional hazard model. A P value of <0.05 was considered significant. Results: A total of 120 patients with 120 LR-M lesions were included; on histology 65 were HCC and 55 were iCCA. There was similar median OS for patients with LR-M HCC compared to patients with iCCA (738 days vs. 769 days, P = 0.576). There were no significant differences between patients with HCC and iCCA in terms of sex (47:18 vs. 37:18, P = 0.549), age (63.0 ± 8.4 vs. 63.4 ± 7.8, P = 0.847), etiology of liver disease (P = 0.202), presence of cirrhosis (100% vs. 100%, P = 1.000), tumor size (4.73 ± 3.28 vs. 4.75 ± 2.58, P = 0.980), method of lesion histologic diagnosis (P = 0.646), and proportion of patients who underwent locoregional therapy (60.0% vs. 38.2%, P = 0.100) or surgery (134.8 ± 165.5 vs. 142.5 ± 205.6, P = 0.913). Using multivariable analysis, nonsurgical compared to surgical management (HR, 4.58), larger tumor size (HR, 1.19), and higher MELD score (HR, 1.12) were independently associated with worse OS. Data conclusion: There was similar OS in patients with LR-M HCC and LR-M iCCA, suggesting that LR-M imaging features may more closely reflect patient outcomes than histology. Evidence level: 3 TECHNICAL EFFICACY: Stage 5. |
---|---|
MeSH term(s) | Male ; Humans ; Female ; Middle Aged ; Aged ; Carcinoma, Hepatocellular/pathology ; Liver Neoplasms/surgery ; Retrospective Studies ; Magnetic Resonance Imaging/methods ; Cholangiocarcinoma/diagnostic imaging ; Bile Duct Neoplasms/diagnostic imaging ; Bile Ducts, Intrahepatic ; Contrast Media |
Chemical Substances | Contrast Media |
Language | English |
Publishing date | 2022-05-05 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 1146614-5 |
ISSN | 1522-2586 ; 1053-1807 |
ISSN (online) | 1522-2586 |
ISSN | 1053-1807 |
DOI | 10.1002/jmri.28218 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3648: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 236: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.